Yan Ji-Qi, Becker Thomas, Peng Cheng-Hong, Li Hong-Wei, Klempnauer Juergen
Department of Surgery, Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai 200025, China.
Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):339-44.
Orthotopic liver transplantation as a successful treatment of end-stage liver disease is hampered by a persistent lack of cadaveric organs. Split liver transplantation, which was first successfully performed by Medical School of Hannover in 1988, has become a mature surgical technique to expand the donor pool. Between 1993 and 1999, split liver transplantation activities have increased in Europe from 1.2% to 10.4% in all performed liver transplantations. Current data have strongly supported that the survival rate of patients after split liver transplantation is not significantly different from that of patients after whole-size orthotopic liver transplantation. The most important step of donor graft selection is surgeon's observation judged by the experience of individual transplant center. The paper aims to provide the guideline of donor selection, hepatic graft splitting, and recipient management as well.
Medical School of Hannover has accumulated plentiful experience of split liver transplantation for more than 10 cases ever since 1998. Besides that, we also reviewed a variety of literatures from other famous European and American centers specialized in this field for many years.
According to our experience combined with the view points of others, the donor should meet the following criteria as well: (1) age less than 50 years; (2) hemodynamics stable; (3) ICU less than 5 days; (4) Na less than 170 mmol/L or better if less than 150 mmol/L. In 1996 and 1997, the Hamburg group and the UCLA group separately introduced a breakthrough technique performing split liver transplantation in situ. Evidently, the in situ technique has been limited by prolonged time of donor organ procurement, coordination with other organ procurement teams, and even extra burden on donor hospital. Some groups, therefore, have restored the ex situ or bench splitting technique, and fortunately the transplant outcomes of the ex situ technique are equivalent to those of the in situ one. Recently some new techniques have been introduced to split the liver for two adult patients, including the split-cava technique.
It is clear that the most important factor for determining the prognosis of the patient is the time of receiving liver transplantation, not the type of liver transplantation. We still need to pay close attention to the graft to recipient weight ratio (GRWR) and the UNOS classification or MELD score before the patient is subjected to split liver transplantation.
原位肝移植作为治疗终末期肝病的一种成功方法,因尸体器官持续短缺而受到阻碍。1988年汉诺威医学院首次成功实施的劈离式肝移植,已成为一种成熟的外科技术,可扩大供体库。1993年至1999年间,欧洲劈离式肝移植在所有肝移植手术中的占比从1.2%增至10.4%。目前的数据有力地支持了劈离式肝移植患者的生存率与全尺寸原位肝移植患者的生存率无显著差异。供肝选择最重要的步骤是根据各个移植中心的经验由外科医生进行观察判断。本文旨在提供供体选择、肝移植劈离及受体管理的指导原则。
自1998年以来,汉诺威医学院积累了10余例劈离式肝移植的丰富经验。除此之外,我们还查阅了其他欧美著名专业领域中心多年来的各类文献。
根据我们的经验并结合他人观点,供体还应符合以下标准:(1)年龄小于50岁;(2)血流动力学稳定;(3)入住重症监护病房时间少于5天;(4)血钠低于170 mmol/L,若低于150 mmol/L则更佳。1996年和1997年,汉堡小组和加州大学洛杉矶分校小组分别引入了一项突破性技术,即原位劈离式肝移植。显然,原位技术受到供体器官获取时间延长、与其他器官获取团队协调以及给供体医院带来额外负担等因素的限制。因此,一些小组恢复了异位或体外劈离技术,幸运的是,异位技术的移植效果与原位技术相当。最近,一些新技术被引入用于为两名成年患者劈离肝脏,包括劈离下腔静脉技术。
显然,决定患者预后的最重要因素是接受肝移植的时间,而非肝移植的类型。在患者接受劈离式肝移植前,我们仍需密切关注移植物与受体重量比(GRWR)以及美国器官共享联合网络(UNOS)分类或终末期肝病模型(MELD)评分。